Skip to main content
Atrás
Watch Compare

Vistagen Therapeutics, Inc.

Calidad de datos: 83%
VTGN
Nasdaq Manufacturing Chemicals
$0.56
▲ $0.01 (1.60%)
Cap. Mercado: 22.15 M
Precio
$0.56
Cap. Mercado
22.15 M
Rango del Día
$0.53 — $0.57
Rango de 52 Semanas
$0.43 — $5.14
Volumen
154,131
Apertura $0.55
Promedio 50D / 200D
$0.59
4.44% below
Promedio 50D / 200D
$2.39
76.58% below

Quick Summary

Puntos Clave

Negative free cash flow of -60.30 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-114.36%
Below sector avg (-53.41%)
ROIC-92.96%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.67
Interest CoverageN/A

Valoración

PE (TTM)
-0.33
Above sector avg (-1.48)
P/B Ratio0.43
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.3 -1.5
P/B 0.4 1.6
ROE % -114.4 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
4.29% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -67.05 M
ROE -114.36% ROA -91.85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -60.30 M
ROIC -92.96% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.67
Interest Coverage N/A Asset Turnover N/A
Working Capital 49.72 M Tangible Book Value 50.92 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.33 Forward P/E N/A
P/B Ratio 0.43 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -272.25%
Market Cap 22.15 M Enterprise Value -25.22 M
Per Share
EPS (Diluted TTM) -1.90 Revenue / Share N/A
FCF / Share -1.52 OCF / Share -1.52
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.94%
SBC-Adj. FCF -64.49 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — -227,000.0 1.11 M 1.09 M
Net Income -51.42 M -29.36 M -59.25 M -47.76 M -17.93 M
EPS (Diluted) -1.67 -1.52 — — —
Gross Profit — — — — —
Operating Income -55.97 M -33.02 M -59.27 M -47.78 M -17.93 M
EBITDA — — — — —
R&D Expenses 39.38 M 20.02 M 44.38 M 35.41 M 12.48 M
SG&A Expenses — — — — —
D&A 150,000.0 127,000.0 129,500.0 153,500.0 117,600.0
Interest Expense — — 26,200.0 19,900.0 1,600.0
Income Tax 7,000.0 4,000.0 5,900.0 3,400.0 2,600.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 84.34 M 123.65 M 21.09 M 74.64 M 108.28 M
Total Liabilities 13.95 M 9.37 M 9.01 M 9.93 M 16.30 M
Shareholders' Equity 70.39 M 114.29 M 12.08 M 64.72 M 91.98 M
Total Debt — — — — —
Cash & Equivalents 67.13 M 119.17 M 16.64 M 68.14 M 103.11 M
Current Assets 82.08 M 120.67 M 17.51 M 71.00 M 104.12 M
Current Liabilities 12.61 M 5.12 M 4.57 M 5.77 M 4.19 M